Seeking Alpha

Trillium adds to TTI-621-stoked rally, up 22%

|About: Trillium Therapeutics ... (TRIL)|By: , SA News Editor

Trillium (TRIL +22%) is up, yet again, this time on a 7x surge in volume in early trade. Shares have more than tripled since year-end.

On January 7, it announced positive interim data from an early-stage study of TTI-621 in heavily pretreated lymphoma patients.

Try Seeking Alpha PREMIUM for unlimited analysis on TRIL